FDA
-
Johnson & Johnson's COVID-19 Vaccine Links to Guillain-Barré Syndrome, Paralysis, FDA Warns
-
Pfizer COVID-19 Booster to Get FDA Approval in August, Third Shot to Significantly Improve Immunity
-
FDA’s Approval for Alzheimer’s Drug Sparks Resignation Calls
-
FDA Approves Alzheimer's Drug 'Aducanumab,' Which Target Dementia Forms Over Symptoms
-
Check Your Sunscreens Now: Valisure Warns FDA, Suggests High Levels of Cancer-Causing Substance on Skincare Products
-
Pfizer Vaccine to be FDA-Authorized for 12 to 15-Year Olds Next Week
-
First Prescription Video Game Receives FDA Approval--A Post-COVID Treatment for Persons with ADHD
-
FDA, CDC Halts J&J COVID-19 Vaccine's Use: Vaccinated People With These Symptoms Advised to Contact Health Experts
-
Amazon Gets Approval from the FDA to Use their Own At-Home COVID-19 Test Kits for Employees
-
Johnson & Johnson's One-Dose COVID-19 Vaccine Is Effective in Providing Protection From Contagious Variants, New Analyses Show
-
Israel Creates First-Ever 3D Bio-Printed Steak Using Live Animal Cells as Opposed to Vegan Options
-
First Long-Acting HIV Two-Shot Combo Gets FDA Approval Aimed to Help Patients Track Medication Better
Most Popular
